Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 17 | 2024 | 98 | 5.040 |
Why?
|
Transanal Endoscopic Surgery | 10 | 2024 | 23 | 3.910 |
Why?
|
Digestive System Surgical Procedures | 14 | 2023 | 88 | 3.350 |
Why?
|
Rectum | 14 | 2024 | 86 | 2.910 |
Why?
|
Laparoscopy | 22 | 2023 | 426 | 2.720 |
Why?
|
Colonoscopy | 9 | 2022 | 86 | 2.190 |
Why?
|
Colectomy | 16 | 2019 | 104 | 1.950 |
Why?
|
Anastomotic Leak | 5 | 2024 | 33 | 1.850 |
Why?
|
Colonic Neoplasms | 10 | 2023 | 215 | 1.780 |
Why?
|
Colon | 10 | 2024 | 136 | 1.660 |
Why?
|
Colorectal Neoplasms | 8 | 2022 | 263 | 1.580 |
Why?
|
Postoperative Complications | 26 | 2024 | 1202 | 1.500 |
Why?
|
Crohn Disease | 8 | 2021 | 105 | 1.440 |
Why?
|
Anus Diseases | 3 | 2023 | 7 | 1.400 |
Why?
|
Anastomosis, Surgical | 6 | 2024 | 107 | 1.350 |
Why?
|
Colorectal Surgery | 7 | 2021 | 53 | 1.240 |
Why?
|
Hemorrhoids | 2 | 2023 | 4 | 1.230 |
Why?
|
Colonic Polyps | 2 | 2022 | 25 | 1.210 |
Why?
|
Colostomy | 3 | 2022 | 23 | 1.200 |
Why?
|
Adenocarcinoma | 5 | 2019 | 323 | 1.150 |
Why?
|
Treatment Outcome | 31 | 2024 | 5283 | 1.070 |
Why?
|
Ileostomy | 3 | 2024 | 25 | 1.030 |
Why?
|
Colitis, Ulcerative | 4 | 2020 | 71 | 1.020 |
Why?
|
Perineum | 4 | 2021 | 19 | 1.020 |
Why?
|
Hemorrhoidectomy | 2 | 2023 | 2 | 1.000 |
Why?
|
Humans | 100 | 2024 | 59282 | 1.000 |
Why?
|
Middle Aged | 55 | 2024 | 16310 | 1.000 |
Why?
|
Rectal Diseases | 5 | 2020 | 28 | 0.950 |
Why?
|
Diverticulitis | 3 | 2020 | 28 | 0.950 |
Why?
|
Retrospective Studies | 40 | 2024 | 6071 | 0.900 |
Why?
|
Surgeons | 3 | 2021 | 161 | 0.880 |
Why?
|
Colonic Pouches | 2 | 2020 | 16 | 0.860 |
Why?
|
Proctocolectomy, Restorative | 2 | 2020 | 18 | 0.860 |
Why?
|
Elective Surgical Procedures | 9 | 2021 | 112 | 0.830 |
Why?
|
Colonic Diseases | 7 | 2020 | 34 | 0.810 |
Why?
|
Pelvis | 2 | 2021 | 58 | 0.810 |
Why?
|
Diverticulitis, Colonic | 5 | 2020 | 32 | 0.800 |
Why?
|
Female | 65 | 2024 | 30695 | 0.790 |
Why?
|
Male | 65 | 2024 | 27727 | 0.790 |
Why?
|
Digestive System Fistula | 1 | 2021 | 3 | 0.760 |
Why?
|
Reoperation | 3 | 2021 | 272 | 0.720 |
Why?
|
Tomography, X-Ray Computed | 6 | 2019 | 1525 | 0.690 |
Why?
|
Clostridium Infections | 1 | 2020 | 45 | 0.660 |
Why?
|
Academic Medical Centers | 3 | 2017 | 306 | 0.650 |
Why?
|
Embolism, Air | 1 | 2018 | 8 | 0.630 |
Why?
|
Delphi Technique | 1 | 2019 | 77 | 0.630 |
Why?
|
Length of Stay | 11 | 2021 | 775 | 0.620 |
Why?
|
Carbon Dioxide | 1 | 2018 | 81 | 0.610 |
Why?
|
Anal Canal | 4 | 2023 | 34 | 0.580 |
Why?
|
Patient Readmission | 5 | 2020 | 420 | 0.560 |
Why?
|
Aged | 38 | 2024 | 13412 | 0.560 |
Why?
|
Telemedicine | 1 | 2022 | 307 | 0.560 |
Why?
|
Rectal Fistula | 2 | 2015 | 20 | 0.550 |
Why?
|
Adult | 37 | 2024 | 15663 | 0.530 |
Why?
|
Abscess | 2 | 2015 | 76 | 0.530 |
Why?
|
Total Quality Management | 1 | 2015 | 56 | 0.490 |
Why?
|
Quality Improvement | 9 | 2019 | 416 | 0.490 |
Why?
|
Neoplasm Staging | 8 | 2023 | 452 | 0.470 |
Why?
|
Patient Safety | 1 | 2017 | 237 | 0.470 |
Why?
|
Efficiency, Organizational | 1 | 2015 | 94 | 0.470 |
Why?
|
Chemoradiotherapy, Adjuvant | 1 | 2014 | 9 | 0.470 |
Why?
|
Fecal Incontinence | 3 | 2024 | 28 | 0.460 |
Why?
|
Pain, Postoperative | 4 | 2023 | 141 | 0.450 |
Why?
|
Stromal Cells | 1 | 2014 | 65 | 0.440 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 78 | 0.440 |
Why?
|
Healthcare Disparities | 3 | 2023 | 326 | 0.440 |
Why?
|
Anus Neoplasms | 3 | 2022 | 23 | 0.420 |
Why?
|
Colon, Sigmoid | 2 | 2013 | 10 | 0.410 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 254 | 0.400 |
Why?
|
Rectal Prolapse | 3 | 2019 | 11 | 0.400 |
Why?
|
Morbidity | 6 | 2021 | 112 | 0.390 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 483 | 0.390 |
Why?
|
Enteral Nutrition | 2 | 2002 | 54 | 0.380 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 112 | 0.380 |
Why?
|
Risk Assessment | 7 | 2020 | 1920 | 0.370 |
Why?
|
Gastrointestinal Diseases | 1 | 2011 | 69 | 0.370 |
Why?
|
Health Status Disparities | 2 | 2013 | 137 | 0.360 |
Why?
|
Internship and Residency | 6 | 2020 | 740 | 0.350 |
Why?
|
General Surgery | 3 | 2020 | 191 | 0.340 |
Why?
|
Cutaneous Fistula | 2 | 2015 | 7 | 0.330 |
Why?
|
Risk Factors | 19 | 2020 | 4982 | 0.330 |
Why?
|
Patient Discharge | 4 | 2021 | 489 | 0.310 |
Why?
|
United States | 18 | 2024 | 7385 | 0.310 |
Why?
|
Intubation, Gastrointestinal | 2 | 2014 | 20 | 0.310 |
Why?
|
Surgical Procedures, Operative | 3 | 2015 | 137 | 0.300 |
Why?
|
Operative Time | 2 | 2021 | 76 | 0.300 |
Why?
|
Follow-Up Studies | 7 | 2021 | 2337 | 0.300 |
Why?
|
Minimally Invasive Surgical Procedures | 4 | 2016 | 98 | 0.300 |
Why?
|
Margins of Excision | 3 | 2024 | 24 | 0.290 |
Why?
|
Surgical Wound Infection | 3 | 2014 | 110 | 0.290 |
Why?
|
Surgical Flaps | 2 | 2023 | 110 | 0.290 |
Why?
|
Recurrence | 3 | 2020 | 602 | 0.270 |
Why?
|
Proctitis | 2 | 2020 | 6 | 0.270 |
Why?
|
Prospective Studies | 6 | 2024 | 3065 | 0.270 |
Why?
|
Aged, 80 and over | 13 | 2021 | 5128 | 0.260 |
Why?
|
Feasibility Studies | 2 | 2021 | 525 | 0.260 |
Why?
|
Patient Satisfaction | 2 | 2022 | 412 | 0.260 |
Why?
|
Practice Patterns, Physicians' | 4 | 2021 | 687 | 0.260 |
Why?
|
Education, Medical, Graduate | 3 | 2020 | 315 | 0.250 |
Why?
|
Colitis | 1 | 2006 | 75 | 0.240 |
Why?
|
Intestinal Obstruction | 2 | 2018 | 49 | 0.240 |
Why?
|
Adolescent | 10 | 2022 | 5822 | 0.240 |
Why?
|
Quality of Life | 3 | 2024 | 1137 | 0.240 |
Why?
|
Urinary Incontinence | 2 | 2015 | 40 | 0.230 |
Why?
|
Cohort Studies | 5 | 2022 | 2372 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 299 | 0.220 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2014 | 33 | 0.220 |
Why?
|
Preoperative Care | 3 | 2019 | 180 | 0.220 |
Why?
|
Mesocolon | 1 | 2023 | 2 | 0.220 |
Why?
|
Databases, Factual | 6 | 2016 | 813 | 0.220 |
Why?
|
Perioperative Period | 2 | 2021 | 19 | 0.210 |
Why?
|
Intestinal Fistula | 1 | 2003 | 10 | 0.210 |
Why?
|
Consumer Health Information | 1 | 2022 | 36 | 0.200 |
Why?
|
Home Care Services | 2 | 2020 | 97 | 0.200 |
Why?
|
Critical Care | 3 | 2016 | 397 | 0.200 |
Why?
|
Feces | 2 | 2020 | 97 | 0.200 |
Why?
|
Gastric Emptying | 1 | 2002 | 6 | 0.200 |
Why?
|
Propranolol | 1 | 2002 | 21 | 0.200 |
Why?
|
Survival Rate | 5 | 2015 | 802 | 0.200 |
Why?
|
Hospital Mortality | 3 | 2017 | 841 | 0.200 |
Why?
|
Personal Satisfaction | 1 | 2022 | 76 | 0.190 |
Why?
|
Sarcopenia | 1 | 2022 | 18 | 0.190 |
Why?
|
Burns | 1 | 2002 | 41 | 0.190 |
Why?
|
Health Services Accessibility | 3 | 2015 | 521 | 0.190 |
Why?
|
Medical Chaperones | 1 | 2021 | 3 | 0.190 |
Why?
|
Abdominal Pain | 1 | 2022 | 94 | 0.190 |
Why?
|
Oxycodone | 1 | 2021 | 30 | 0.190 |
Why?
|
Military Personnel | 2 | 2013 | 97 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 236 | 0.180 |
Why?
|
Aftercare | 1 | 2021 | 69 | 0.180 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 147 | 0.180 |
Why?
|
Energy Intake | 1 | 2002 | 167 | 0.180 |
Why?
|
Drainage | 3 | 2013 | 148 | 0.180 |
Why?
|
Abdomen | 3 | 2016 | 91 | 0.180 |
Why?
|
Treatment Failure | 1 | 2021 | 185 | 0.180 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2020 | 17 | 0.170 |
Why?
|
Safety | 1 | 2021 | 142 | 0.170 |
Why?
|
Granuloma, Plasma Cell | 1 | 2020 | 2 | 0.170 |
Why?
|
Herpesvirus 2, Human | 1 | 2020 | 10 | 0.170 |
Why?
|
Inappropriate Prescribing | 1 | 2021 | 64 | 0.170 |
Why?
|
Prognosis | 5 | 2014 | 1599 | 0.170 |
Why?
|
Online Systems | 1 | 2020 | 19 | 0.170 |
Why?
|
Drug Prescriptions | 1 | 2021 | 168 | 0.170 |
Why?
|
Laparotomy | 2 | 2015 | 47 | 0.170 |
Why?
|
Terminology as Topic | 1 | 2021 | 133 | 0.170 |
Why?
|
Reproducibility of Results | 2 | 2022 | 1561 | 0.170 |
Why?
|
Precancerous Conditions | 2 | 2013 | 70 | 0.170 |
Why?
|
Herpes Simplex | 1 | 2020 | 48 | 0.160 |
Why?
|
Skilled Nursing Facilities | 1 | 2020 | 83 | 0.160 |
Why?
|
Intestinal Diseases | 2 | 2014 | 34 | 0.160 |
Why?
|
Surveys and Questionnaires | 3 | 2024 | 2511 | 0.160 |
Why?
|
Drug Utilization | 1 | 2021 | 208 | 0.160 |
Why?
|
Herpesvirus 1, Human | 1 | 2020 | 78 | 0.160 |
Why?
|
Energy Metabolism | 1 | 2002 | 359 | 0.160 |
Why?
|
Insurance Coverage | 2 | 2016 | 94 | 0.160 |
Why?
|
Time Factors | 7 | 2019 | 3614 | 0.160 |
Why?
|
Unnecessary Procedures | 2 | 2016 | 43 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 169 | 0.160 |
Why?
|
Young Adult | 10 | 2016 | 4266 | 0.150 |
Why?
|
Social Media | 1 | 2020 | 117 | 0.150 |
Why?
|
Intestine, Small | 1 | 2018 | 76 | 0.150 |
Why?
|
Pregnancy Complications | 2 | 2014 | 364 | 0.140 |
Why?
|
Colon, Transverse | 1 | 2017 | 4 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2021 | 902 | 0.140 |
Why?
|
Hospital Costs | 2 | 2014 | 119 | 0.140 |
Why?
|
Early Detection of Cancer | 3 | 2015 | 266 | 0.130 |
Why?
|
Logistic Models | 5 | 2014 | 1232 | 0.130 |
Why?
|
Adenoma | 2 | 2013 | 64 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 933 | 0.120 |
Why?
|
Cholangiography | 1 | 2015 | 42 | 0.120 |
Why?
|
Cholecystectomy | 1 | 2015 | 31 | 0.120 |
Why?
|
Hernia | 1 | 2015 | 15 | 0.120 |
Why?
|
Odds Ratio | 2 | 2020 | 745 | 0.120 |
Why?
|
Parenteral Nutrition | 2 | 2006 | 21 | 0.120 |
Why?
|
Severity of Illness Index | 5 | 2016 | 1479 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 95 | 0.120 |
Why?
|
Bibliometrics | 1 | 2015 | 27 | 0.120 |
Why?
|
Robotic Surgical Procedures | 1 | 2017 | 115 | 0.120 |
Why?
|
Fat Emulsions, Intravenous | 2 | 2006 | 37 | 0.120 |
Why?
|
Specimen Handling | 1 | 2015 | 61 | 0.120 |
Why?
|
Program Development | 1 | 2015 | 203 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2014 | 43 | 0.110 |
Why?
|
Herniorrhaphy | 1 | 2015 | 69 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2015 | 110 | 0.110 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 72 | 0.110 |
Why?
|
Recovery of Function | 2 | 2013 | 270 | 0.110 |
Why?
|
Megacolon | 1 | 2014 | 1 | 0.110 |
Why?
|
Incidence | 4 | 2014 | 1236 | 0.110 |
Why?
|
Fluorouracil | 1 | 2014 | 55 | 0.110 |
Why?
|
Lacerations | 1 | 2014 | 16 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 39 | 0.110 |
Why?
|
Pilonidal Sinus | 1 | 2013 | 2 | 0.110 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2013 | 4 | 0.110 |
Why?
|
Tissue Adhesives | 1 | 2013 | 9 | 0.110 |
Why?
|
Liver Failure | 1 | 2013 | 17 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 49 | 0.110 |
Why?
|
Obstetric Labor Complications | 1 | 2014 | 24 | 0.110 |
Why?
|
Population Surveillance | 1 | 2015 | 194 | 0.110 |
Why?
|
Vancomycin | 1 | 2014 | 36 | 0.110 |
Why?
|
Publishing | 1 | 2015 | 90 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2014 | 61 | 0.110 |
Why?
|
Tertiary Healthcare | 1 | 2013 | 13 | 0.110 |
Why?
|
Intensive Care Units | 4 | 2020 | 423 | 0.110 |
Why?
|
Emergency Treatment | 1 | 2013 | 52 | 0.110 |
Why?
|
Appendicitis | 1 | 2014 | 74 | 0.110 |
Why?
|
HIV Infections | 1 | 2020 | 912 | 0.100 |
Why?
|
Mice, SCID | 1 | 2014 | 512 | 0.100 |
Why?
|
Defecation | 1 | 2012 | 14 | 0.100 |
Why?
|
Hospitals, Community | 1 | 2013 | 70 | 0.100 |
Why?
|
Cesarean Section | 1 | 2014 | 95 | 0.100 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 34 | 0.100 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 516 | 0.100 |
Why?
|
Reflex | 1 | 2012 | 27 | 0.100 |
Why?
|
Urinary Bladder | 1 | 2012 | 38 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 1025 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2015 | 166 | 0.100 |
Why?
|
Fibroblasts | 1 | 2014 | 377 | 0.100 |
Why?
|
Mentors | 1 | 2013 | 115 | 0.100 |
Why?
|
Biomedical Research | 1 | 2015 | 249 | 0.100 |
Why?
|
Minority Groups | 1 | 2013 | 135 | 0.100 |
Why?
|
Observation | 1 | 2011 | 29 | 0.100 |
Why?
|
Medical Records | 1 | 2012 | 133 | 0.100 |
Why?
|
Sepsis | 1 | 2015 | 272 | 0.090 |
Why?
|
Patient Care Team | 1 | 2014 | 326 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 224 | 0.090 |
Why?
|
Ultrasonography | 1 | 2013 | 459 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2013 | 290 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 705 | 0.090 |
Why?
|
Pregnancy | 3 | 2014 | 2202 | 0.080 |
Why?
|
Ligation | 1 | 2010 | 33 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 132 | 0.080 |
Why?
|
Muscle, Skeletal | 2 | 2006 | 674 | 0.080 |
Why?
|
Acute Disease | 3 | 2016 | 659 | 0.080 |
Why?
|
Postoperative Period | 2 | 2013 | 127 | 0.080 |
Why?
|
Insulin | 2 | 2002 | 674 | 0.080 |
Why?
|
Animals | 5 | 2014 | 19601 | 0.080 |
Why?
|
Data Accuracy | 2 | 2020 | 28 | 0.070 |
Why?
|
Life Style | 1 | 2010 | 299 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 730 | 0.070 |
Why?
|
Internet | 2 | 2022 | 449 | 0.070 |
Why?
|
Comorbidity | 3 | 2017 | 1078 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 674 | 0.070 |
Why?
|
Emergencies | 2 | 2010 | 111 | 0.070 |
Why?
|
Disease Models, Animal | 1 | 2014 | 2046 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 2373 | 0.060 |
Why?
|
Inpatients | 2 | 2021 | 291 | 0.060 |
Why?
|
Propensity Score | 2 | 2015 | 144 | 0.060 |
Why?
|
Fatty Acids | 1 | 2006 | 190 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 2059 | 0.060 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2024 | 21 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2011 | 862 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2006 | 203 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 56 | 0.060 |
Why?
|
Obesity | 1 | 2011 | 1166 | 0.050 |
Why?
|
Washington | 2 | 2013 | 23 | 0.050 |
Why?
|
Search Engine | 1 | 2022 | 9 | 0.050 |
Why?
|
Blood Glucose | 2 | 2002 | 461 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2002 | 7 | 0.050 |
Why?
|
Intestines | 1 | 2004 | 158 | 0.050 |
Why?
|
Workload | 2 | 2014 | 118 | 0.050 |
Why?
|
Pylorus | 1 | 2002 | 10 | 0.050 |
Why?
|
Syndrome | 1 | 2022 | 170 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2023 | 396 | 0.050 |
Why?
|
Nutritional Status | 1 | 2003 | 93 | 0.050 |
Why?
|
Jejunum | 1 | 2002 | 14 | 0.050 |
Why?
|
Glycogen | 1 | 2002 | 38 | 0.050 |
Why?
|
Skin Diseases | 1 | 2003 | 76 | 0.050 |
Why?
|
Dietary Carbohydrates | 1 | 2002 | 58 | 0.050 |
Why?
|
Postoperative Care | 1 | 2002 | 114 | 0.050 |
Why?
|
Organizational Policy | 1 | 2021 | 47 | 0.050 |
Why?
|
Comprehension | 1 | 2022 | 131 | 0.050 |
Why?
|
Program Evaluation | 2 | 2014 | 470 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2003 | 189 | 0.050 |
Why?
|
Liver | 1 | 2006 | 796 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2002 | 111 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 442 | 0.040 |
Why?
|
Mice | 1 | 2014 | 10251 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 192 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 1252 | 0.040 |
Why?
|
Outpatients | 1 | 2021 | 136 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 13 | 0.040 |
Why?
|
Accreditation | 1 | 2020 | 73 | 0.040 |
Why?
|
Age Factors | 2 | 2014 | 1504 | 0.040 |
Why?
|
Computer Terminals | 1 | 1999 | 5 | 0.040 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2020 | 44 | 0.040 |
Why?
|
Glucose | 1 | 2002 | 445 | 0.040 |
Why?
|
Laparoscopes | 1 | 1999 | 24 | 0.040 |
Why?
|
Long-Term Care | 1 | 2020 | 176 | 0.040 |
Why?
|
Superior Mesenteric Artery Syndrome | 1 | 2018 | 1 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2019 | 214 | 0.040 |
Why?
|
Tissue Adhesions | 1 | 2018 | 19 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2019 | 55 | 0.040 |
Why?
|
Universities | 1 | 2019 | 144 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 39 | 0.040 |
Why?
|
Critical Illness | 1 | 2002 | 325 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2020 | 173 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 2006 | 574 | 0.040 |
Why?
|
Child | 2 | 2020 | 4173 | 0.040 |
Why?
|
Self Report | 1 | 2021 | 359 | 0.040 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 69 | 0.040 |
Why?
|
Needs Assessment | 1 | 2019 | 187 | 0.040 |
Why?
|
Pancreas | 1 | 2018 | 147 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2020 | 311 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 56 | 0.030 |
Why?
|
Rats | 3 | 2006 | 1909 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2020 | 1283 | 0.030 |
Why?
|
Occult Blood | 1 | 2015 | 16 | 0.030 |
Why?
|
Colonography, Computed Tomographic | 1 | 2015 | 20 | 0.030 |
Why?
|
Hospitals, High-Volume | 1 | 2016 | 32 | 0.030 |
Why?
|
Tertiary Care Centers | 1 | 2016 | 100 | 0.030 |
Why?
|
Symptom Assessment | 1 | 2015 | 43 | 0.030 |
Why?
|
Infant | 1 | 2020 | 1486 | 0.030 |
Why?
|
Fissure in Ano | 1 | 2015 | 1 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1999 | 653 | 0.030 |
Why?
|
Hospital Charges | 1 | 2015 | 23 | 0.030 |
Why?
|
Bile | 1 | 2015 | 19 | 0.030 |
Why?
|
Medical Illustration | 1 | 2015 | 3 | 0.030 |
Why?
|
Hawaii | 1 | 2015 | 22 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2015 | 36 | 0.030 |
Why?
|
Child, Preschool | 1 | 2020 | 1782 | 0.030 |
Why?
|
Surgical Mesh | 1 | 2015 | 58 | 0.030 |
Why?
|
Phospholipids | 2 | 2006 | 78 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 130 | 0.030 |
Why?
|
Obstetrical Forceps | 1 | 2014 | 2 | 0.030 |
Why?
|
Episiotomy | 1 | 2014 | 2 | 0.030 |
Why?
|
Vacuum Extraction, Obstetrical | 1 | 2014 | 2 | 0.030 |
Why?
|
Enema | 1 | 2014 | 12 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 355 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 47 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 97 | 0.030 |
Why?
|
Cost of Illness | 1 | 2014 | 156 | 0.030 |
Why?
|
United States Department of Defense | 1 | 2013 | 1 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 2013 | 6 | 0.030 |
Why?
|
Wounds, Penetrating | 1 | 2013 | 23 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 332 | 0.030 |
Why?
|
Ileum | 1 | 2013 | 19 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2013 | 101 | 0.030 |
Why?
|
ROC Curve | 1 | 2013 | 266 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 297 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2013 | 228 | 0.030 |
Why?
|
Gastroenterology | 1 | 2013 | 35 | 0.030 |
Why?
|
Patient Selection | 1 | 2015 | 464 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 103 | 0.020 |
Why?
|
Liver Diseases | 1 | 2013 | 138 | 0.020 |
Why?
|
Sex Factors | 1 | 2015 | 935 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 58 | 0.020 |
Why?
|
Clinical Competence | 2 | 2012 | 682 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 75 | 0.020 |
Why?
|
Teaching | 1 | 2013 | 152 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 441 | 0.020 |
Why?
|
Research Design | 1 | 2015 | 555 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 741 | 0.020 |
Why?
|
Societies, Medical | 1 | 2013 | 335 | 0.020 |
Why?
|
Massachusetts | 1 | 2016 | 2003 | 0.020 |
Why?
|
Registries | 1 | 2014 | 801 | 0.020 |
Why?
|
Mass Screening | 1 | 2015 | 645 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 409 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 243 | 0.020 |
Why?
|
Hospitalization | 1 | 2016 | 1290 | 0.020 |
Why?
|
Decision Making | 1 | 2012 | 394 | 0.020 |
Why?
|
Weight Loss | 1 | 2010 | 263 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 831 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 976 | 0.020 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2006 | 6 | 0.020 |
Why?
|
Short Bowel Syndrome | 1 | 2006 | 5 | 0.020 |
Why?
|
Smoking | 1 | 2010 | 826 | 0.020 |
Why?
|
Random Allocation | 1 | 2006 | 192 | 0.020 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2006 | 36 | 0.020 |
Why?
|
Soybean Oil | 1 | 2004 | 31 | 0.010 |
Why?
|
Ghrelin | 1 | 2002 | 18 | 0.010 |
Why?
|
Animal Feed | 1 | 2002 | 16 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 164 | 0.010 |
Why?
|
Nutritional Support | 1 | 2002 | 12 | 0.010 |
Why?
|
Models, Educational | 1 | 1999 | 66 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 1999 | 122 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2002 | 249 | 0.010 |
Why?
|